國立高雄大學圖資館 |

登入

回首頁

Malarial drug delivery systemsadvances in treatment of infectious diseases /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Malarial drug delivery systemsedited by Ranjita Shegokar, Yashwant Pathak.
其他題名:	advances in treatment of infectious diseases /
其他作者:	Shegokar, Ranjita.
出版者:	Cham :Springer International Publishing :2023.
面頁冊數:	x, 395 p. :ill. (chiefly col.), digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	MalariaChemotherapy.
電子資源:	https://doi.org/10.1007/978-3-031-15848-3
ISBN:	9783031158483$q(electronic bk.)

Malarial drug delivery systemsadvances in treatment of infectious diseases /
Malarial drug delivery systemsadvances in treatment of infectious diseases /[electronic resource] :edited by Ranjita Shegokar, Yashwant Pathak. - Cham :Springer International Publishing :2023. - x, 395 p. :ill. (chiefly col.), digital ;24 cm.

Malaria: Cellular Understanding of Disease -- Drug Resistance, Statistics and Patent Status -- Malaria: Current Treatment Options -- Polymeric Nanoparticles in Malaria -- Solid Lipid Nanoparticles in Malaria -- Dendrimers in Malaria -- Liposomes in Malaria -- Micro and Nano Emulsions in Malaria -- Nanosuspension in Malaria -- Alginate and Gelatin Nanoparticles in Malaria -- Niosomes in Malaria -- Metal Nanoparticles in Malaria -- Nanotechnology in Malaria Diagnosis -- Nanotechnology-based Vaccination -- Herbal Platforms in Malaria -- Surface-modified Drug Delivery Systems in Malaria,- Clinical Trials in Malaria -- Malaria-Overall Picture -- New Drugs in Synthesis Research for Malaria -- Disease Models In Malaria Research.

The disability-adjusted life year (DALY) is a generic measure of health effect that can be used in cost-effectiveness analysis as an alternative to the quality-adjusted life year (QALY) Infectious diseases are one of the major to cause of significant losses of DALY and QALY. Human infectious diseases are disorders that are triggered by the micro-organisms such as bacteria, fungi, viruses, or parasites. The majority of such diseases are contagious and create a public health menace. There are several reasons why infectious diseases are deadly diseases, and one of the primary reasons is the drug resistance developed over time. Drug resistance-associated mutations are linked to increasing drug efflux, modifications of the drugs, or their targets. Every year, new drugs are being approved by FDA to treat infectious diseases. Nonetheless, infectious diseases will undoubtedly persist as permanent and main threats to humanity for now and in the future, primarily due to increased longevity that almost always comes at the cost of impaired immunity. A total of four books are covered under the series of Infectious drug diseases. - Malarial drug delivery systems - Tubercular drug delivery systems - Viral drug delivery systems - Infectious disease drug delivery systems The theme of the first book is Malaria. This book compiles the complete road map of malarial drug delivery systems by understanding the pathophysiology of the disease, the current state of malaria across the globe, new clinical trials, emerging drugs, and the development of novel drug delivery platforms. Various novel micro-and nano-formulations using promising technologies are being explored to deliver the malarial drug via different administration routes. This book addresses the gap between new approaches and old treatment modalities and how the former is superior in pharmacological performance when tested in in-vitro and in-vivo. Audiences from a broad range of groups, from researchers, academicians, and public health bodies to regulatory experts, can benefit from the compiled information to learn more about patient needs and current research advances in the field of malarial research.

ISBN: 9783031158483$q(electronic bk.)

Standard No.: 10.1007/978-3-031-15848-3doiSubjects--Topical Terms:

559396
Malaria
--Chemotherapy.

LC Class. No.: RC159.A5

Dewey Class. No.: 616.962061

Malarial drug delivery systemsadvances in treatment of infectious diseases /
LDR:03949nmm a2200325 a 4500 001 642181
003 DE-He213
005 20230306075620.0
006 m d
007 cr nn 008maaau
008 231123s2023 sz s 0 eng d
020 $a 9783031158483$q(electronic bk.)
020 $a 9783031158476$q(paper)
024 7 $a 10.1007/978-3-031-15848-3 $2 doi
035 $a 978-3-031-15848-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC159.A5
072 7 $a TCB $2 bicssc
072 7 $a SCI010000 $2 bisacsh
072 7 $a TCB $2 thema
082 0 4 $a 616.962061 $2 23
090 $a RC159.A5 $b M237 2023
245 0 0 $a Malarial drug delivery systems $h [electronic resource] : $b advances in treatment of infectious diseases / $c edited by Ranjita Shegokar, Yashwant Pathak.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a x, 395 p. : $b ill. (chiefly col.), digital ; $c 24 cm.
505 0 $a Malaria: Cellular Understanding of Disease -- Drug Resistance, Statistics and Patent Status -- Malaria: Current Treatment Options -- Polymeric Nanoparticles in Malaria -- Solid Lipid Nanoparticles in Malaria -- Dendrimers in Malaria -- Liposomes in Malaria -- Micro and Nano Emulsions in Malaria -- Nanosuspension in Malaria -- Alginate and Gelatin Nanoparticles in Malaria -- Niosomes in Malaria -- Metal Nanoparticles in Malaria -- Nanotechnology in Malaria Diagnosis -- Nanotechnology-based Vaccination -- Herbal Platforms in Malaria -- Surface-modified Drug Delivery Systems in Malaria,- Clinical Trials in Malaria -- Malaria-Overall Picture -- New Drugs in Synthesis Research for Malaria -- Disease Models In Malaria Research.
520 $a The disability-adjusted life year (DALY) is a generic measure of health effect that can be used in cost-effectiveness analysis as an alternative to the quality-adjusted life year (QALY) Infectious diseases are one of the major to cause of significant losses of DALY and QALY. Human infectious diseases are disorders that are triggered by the micro-organisms such as bacteria, fungi, viruses, or parasites. The majority of such diseases are contagious and create a public health menace. There are several reasons why infectious diseases are deadly diseases, and one of the primary reasons is the drug resistance developed over time. Drug resistance-associated mutations are linked to increasing drug efflux, modifications of the drugs, or their targets. Every year, new drugs are being approved by FDA to treat infectious diseases. Nonetheless, infectious diseases will undoubtedly persist as permanent and main threats to humanity for now and in the future, primarily due to increased longevity that almost always comes at the cost of impaired immunity. A total of four books are covered under the series of Infectious drug diseases. - Malarial drug delivery systems - Tubercular drug delivery systems - Viral drug delivery systems - Infectious disease drug delivery systems The theme of the first book is Malaria. This book compiles the complete road map of malarial drug delivery systems by understanding the pathophysiology of the disease, the current state of malaria across the globe, new clinical trials, emerging drugs, and the development of novel drug delivery platforms. Various novel micro-and nano-formulations using promising technologies are being explored to deliver the malarial drug via different administration routes. This book addresses the gap between new approaches and old treatment modalities and how the former is superior in pharmacological performance when tested in in-vitro and in-vivo. Audiences from a broad range of groups, from researchers, academicians, and public health bodies to regulatory experts, can benefit from the compiled information to learn more about patient needs and current research advances in the field of malarial research.
650 0 $a Malaria $x Chemotherapy. $3 559396
650 0 $a Drug delivery systems. $3 196465
650 1 4 $a Drug Delivery. $3 911847
650 2 4 $a Nanobiotechnology. $3 679667
650 2 4 $a Pharmaceutics. $3 913065
650 2 4 $a Tropical Medicine. $3 274942
650 2 4 $a Pharmacology. $3 218135
650 2 4 $a Medical Microbiology. $3 273931
700 1 $a Shegokar, Ranjita. $3 797037
700 1 $a Pathak, Yashwant. $3 520484
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-15848-3
950 $a Biomedical and Life Sciences (SpringerNature-11642)